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Summary & Key Findings
Medicare beneficiaries with diabetes enrolled in chronic condition special needs plans (C-SNPs) experience better outcomes than they would in non-specialized Medicare Advantage (MA) plans. Using a claims-based approach to compare beneficiary outcomes on five clinical and utilization measures, Avalere found that enrollees in a diabetes-focused C-SNP were:
• 22 percent more likely to have a primary care visit,
• 10 percent more likely to receive appropriate diabetes testing,
• 38 percent less likely to have an inpatient hospital admission,
• 32 percent less likely to have a readmission, and • 6 percent more likely to fill (and refill) a prescription for an antidiabetic medication.
These findings held true when controlling for expected differences in enrollees' demographics and health status. The analysis suggests that C-SNPs can improve outcomes for beneficiaries with diabetes compared to non-SNPs.
Background & Objectives
Special needs plans are a type of MA plan that focus on, and limit enrollment to, certain groups of Medicare beneficiaries. SNPs provide targeted services to MA beneficiaries who are institutionalized, are dually eligible for Medicare and Medicaid, or have a severe or disabling chronic condition. SNPs have been offered for more than 10 years, and there are more than 2 million SNP enrollees in 2017. SNPs were originally authorized under the Medicare Modernization Act in 2003 for five years. Congress continues to refine SNP policy and must periodically re-authorize these plans; current SNP authorization expires December 31, 2018.
SNPs are designed to provide coordinated care for some of the Medicare program's most vulnerable beneficiaries, with the ultimate goal of achieving better outcomes for those with significant healthcare needs. SNPs provide their members with tailored benefit packages and provider networks, and must meet requirements beyond those that apply to other MA plans. For example, SNPs must maintain models of care that outline each plan's care coordination, care management, and quality strategies. 1 C-SNPs are offered to beneficiaries with certain specified chronic conditions or sets of cooccurring conditions. The Centers for Medicare & Medicaid Services (CMS) has defined 15 conditions and 5 multi-condition groups that C-SNPs can focus on, including common chronic conditions like diabetes. C-SNPs enroll approximately 15 percent of all SNP beneficiaries. In 2017, nearly all C-SNP enrollees are in plans that focus on diabetes care alone or in combination with cardiovascular disorders (Figure 1 ). Research shows that enrollment in a C-SNP can have positive effects for beneficiaries; for example, one study found that SNP enrollees with diabetes use less inpatient care and more primary care than similar beneficiaries in the fee-for-service program. 3 However, research comparing C-SNPs to other MA plans is limited, and some stakeholders, such as the Medicare Payment Advisory Commission, have asked whether non-SNP MA plans could achieve the same outcomes for beneficiaries with chronic conditions. 
Profile of C-SNP & Non-SNP Enrollees
Avalere first identified MA enrollees with a diagnosis of diabetes who were enrolled in a diabetes-focused C-SNP ("C-SNP enrollees") and, separately, who were enrolled in a non-SNP MA plan ("non-SNP enrollees"). Avalere then compared the C-SNP 5 and non-SNP enrollees across several key demographic and health status factors, including age, presence of comorbidities, socioeconomic characteristics and relative healthcare needs as suggested by risk scores ( Table 1) . As illustrated below, C-SNP enrollees were younger than non-SNP enrollees, and were slightly more likely to be female. C-SNP enrollees were less likely to be white compared to the non-SNP group and were more than twice as likely to be disabled as non-SNP enrollees (49.0% vs. 19.6%).
A significantly larger proportion of C-SNP members are dual eligible (receive both Medicare and Medicaid insurance coverage) indicating they are more likely to be low income and have other social risk factors; 22.7% of C-SNP beneficiaries have partial or full dual status compared to only 8.3% of non-SNP MA beneficiaries. The average income of C-SNP members is indeed much lower, at $40,140 compared to $64,108 for non-SNP members.
As expected, C-SNP enrollees had poorer health status than non-SNP enrollees, as indicated by an average CMS Hierarchical Condition Category (HCC) risk score of 1.6 versus 1.4. 6 In addition, C-SNP enrollees were more likely to have certain chronic conditions including pulmonary conditions (26.7% vs. 19.8%), renal disease (14.2% vs. 10.0%), and behavioral health conditions (13.9% vs. 8.6%). 
Clinical & Utilization Analysis
The objective of this analysis was to determine whether enrollees with diabetes in diabetesfocused C-SNPs experience different outcomes than beneficiaries with diabetes who were enrolled in non-SNP MA plans. Avalere compared C-SNP and non-SNP enrollees' experience across a number of clinical metrics, including use of primary care, use of inpatient care, and diabetes-specific care.
Specifically, Avalere analyzed the:
• Percent of enrollees with one or more primary care physician (PCP) visits • Percent of enrollees receiving one or more HbA1c test 7
• Percent of days covered with antidiabetic medications 8
• Percent of enrollees with one or more inpatient hospital admissions • Percent of enrollees with one or more readmissions within 30 days of a hospital discharge
Avalere then conducted a detailed (i.e., multivariate) analysis of these five measures in order to control for baseline population differences.
Observed (Actual) Outcomes for C-SNP & Non-SNP Enrollees
As illustrated below (Table 2) , C-SNP enrollees were more likely to have a primary care visit than non-SNP enrollees (91.6% vs. 81.5%). C-SNP enrollees were also less likely to use inpatient care, including lower likelihood of hospital admissions (24.4% vs. 25.0%) and lower rates of readmissions (16.3% vs. 17.1%).
C-SNP enrollees were significantly more likely to receive evidence based care as indicated by significantly higher rates of blood sugar levels being evaluated via an HbA1c test (88.1% vs. 69.7%); additionally, C-SNP enrollees were more likely to be adherent to their prescriptions for antidiabetic medications than non-SNP enrollees (82.9% of days covered with a prescription vs. 72.8%). These outcomes are prior to controlling for enrollees' baseline demographic and health status differences, and illustrate that C-SNP enrollees are more likely than non-SNP enrollees to receive diabetes-specific care. For example, the rate of HbA1c testing among C-SNP enrollees was nearly 20 percentage points higher than among non-SNP enrollees before adjusting for demographic and other factors.
7 HbA1c testing is used to determine how well patients' diabetes is being controlled 8 The percent of days covered rate reflects the percentage of days on which a beneficiary had a prescription for an antidiabetic agent, and is used as a proxy for medication adherence. 
Effect of C-SNP Enrollment on Clinical & Utilization Outcomes
While the above unadjusted comparison of C-SNP and non-SNP enrollees offers insight into beneficiary experiences and outcomes, the two groups differed across important demographic, socioeconomic and other risk factors that could impact outcomes and utilization. To provide a more consistent and rigorous comparison between the two populations, Avalere conducted a regression analysis of each of the five outcome measures, controlling for key differences between the two groups.
For each of these five measures, Avalere estimated what the C-SNP enrollees' outcomes would have been if they were enrolled in non-SNP plans. First Avalere modeled the relationship between risk factors and outcomes using the larger non-SNP enrollee group. Avalere then applied these models to the C-SNP enrollees, using their risk factors and characteristics to predict expected outcomes for the C-SNP enrollees -effectively estimating what C-SNP enrollee outcomes with similar profiles would have been in non-SNP plans. The percent difference between C-SNP enrollees' actual outcomes in their C-SNP plan, and what we estimated as their expected outcomes in the non-SNP plan, measures the impact of the C-SNP plan.
The results of the regression analysis show that C-SNP enrollees' outcomes were consistently better when enrolled in the C-SNP than they would have been if they were enrolled in a non-SNP MA plan (Figure 2 ). Note that for inpatient admissions and readmissions, lower rates are better. "Actual" is the average actual outcome for C-SNP enrollees; "expected" is the average predicted outcome for C-SNP enrollees in a non-SNP plan.
In addition, Avalere calculated a "C-SNP effect" by comparing actual versus expected outcomes for C-SNP enrollees (Figure 3) . Avalere estimated that, compared to what it would have been in non-SNP MA plans:
• The percent of C-SNP enrollees with a PCP visit was 22% higher • The number of enrollees who had an HbA1c test was 10% higher;
• The percent of days covered by antidiabetic medications was 6% higher than similar patients in non-SNP MA plans; • The rate of inpatient admissions was 38% lower;
• The rate of readmissions was 32% lower in C-SNP beneficiaries. 
Conclusion
Our analysis demonstrates that outcomes for Medicare beneficiaries with diabetes who are enrolled in a C-SNP are significantly better than would have been realized had those individuals enrolled in a non-SNP MA plan. These findings are based on a multivariate analysis controlling for baseline demographic, socioeconomic, and health status factors. Additionally, these findings are consistent across several domains of care -primary care, inpatient utilization, and diabetes management. As policymakers continue to evaluate and refine the SNP program, this paper offers insight into the value that specialized plans, with models of care tailored to specific chronic conditions, can provide for Medicare beneficiaries with chronic conditions. Plans were identified as being: (1) a SNP specializing in diabetes, alone or in combination with other conditions; (2) some other type of SNP; or (3) a non-SNP. Avalere restricted this analysis to enrollees in diabetes-focused C-SNPs or non-SNPs (i.e., groups 1 and 3 from above). The second additional source of information is an extract of data from the Acxiom Infobase® Geo database that provides the median household size and mean household income for each ZIP+4 (nine-digit) ZIP code in the U.S.; residential ZIP+4 codes typically comprise roughly 10 households. These very specific socioeconomic data have been shown to be strongly associated with the socioeconomic status of individual households as well as strongly associated with medical spending in Medicare.
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Cohort Selection Criteria
The study focuses on beneficiaries with diabetes enrolled either in diabetes-focused C-SNPs or in MA plans that are not SNPs. To be eligible for the study, a member/beneficiary must satisfy the following inclusion criteria: 1. Had ≥1 pharmacy claim with an NDC for antidiabetic medication (i.e., alpha-glucosidase inhibitors, amylin analogs, antidiabetic combinations, insulin, meglitinides, GLP1 agonists, SGLT2 inhibitor, sulfonylureas, thiazolidinediones, or DDP-4 inhibitors) or ≥1 medical claim/encounter (inpatient or outpatient) with a diagnosis for diabetes between January 1, 2015 and December 31, 2015. 2. Had Medicare Advantage as their primary insurance in 2015 and were continuously enrolled in the health plan with claims and pharmacy coverage/benefits with no gap of more than 30 days. 3. Resided in United States (i.e., did not live in the U.S. territories) in 2015 Eligible members (those who met the inclusion criteria above) were assigned to one of the two mutually exclusive cohorts (C-SNP diabetes/C-SNP diabetes and other chronic conditions and Non-SNP). The Non-SNP cohort excluded all special needs plans including D-SNPs (dual eligible members who are also eligible to receive benefits from Medicaid), I-SNPs
